|
1
|
Ishiyama T, Kato I, Ito J, Matsumura M, Saito K, Kawabata Y, Kato S, Takeyama M and Fujii S: Rhabdomyosarcoma with FUS::TFCP2 fusion in the scalp: A rare case report depicting round and spindle cell morphology. Int J Surg Pathol. 31:805–812. 2023. View Article : Google Scholar : PubMed/NCBI
|
|
2
|
Alaggio R, Zhang L, Sung YS, Huang SC, Chen CL, Bisogno G, Zin A, Agaram NP, LaQuaglia MP, Wexler LH and Antonescu CR: A molecular study of pediatric spindle and sclerosing rhabdomyosarcoma: Identification of novel and recurrent VGLL2-related fusions in infantile cases. Am J Surg Pathol. 40:224–235. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
3
|
Karanian M, Pissaloux D, Gomez-Brouchet A, Chevenet C, Le Loarer F, Fernandez C, Minard V, Corradini N, Castex MP, Duc-Gallet A, et al: SRF-FOXO1 and SRF-NCOA1 fusion genes delineate a distinctive subset of well-differentiated rhabdomyosarcoma. Am J Surg Pathol. 44:607–616. 2020. View Article : Google Scholar : PubMed/NCBI
|
|
4
|
Agaram NP, LaQuaglia MP, Alaggio R, Zhang L, Fujisawa Y, Ladanyi M, Wexler LH and Antonescu CR: MYOD1-mutant spindle cell and sclerosing rhabdomyosarcoma: An aggressive subtype irrespective of age. A reappraisal for molecular classification and risk stratification. Mod Pathol. 32:27–36. 2019. View Article : Google Scholar : PubMed/NCBI
|
|
5
|
Agaram NP, Zhang L, Sung YS, Cavalcanti MS, Torrence D, Wexler L, Francis G, Sommerville S, Swanson D, Dickson BC, et al: Expanding the spectrum of intraosseous rhabdomyosarcoma: Correlation between 2 distinct gene fusions and phenotype. Am J Surg Pathol. 43:695–702. 2019. View Article : Google Scholar : PubMed/NCBI
|
|
6
|
Watson S, Perrin V, Guillemot D, Reynaud S, Coindre JM, Karanian M, Guinebretiere JM, Freneaux P, Le Loarer F, Bouvet M, et al: Transcriptomic definition of molecular subgroups of small round cell sarcomas. J Pathol. 245:29–40. 2018. View Article : Google Scholar : PubMed/NCBI
|
|
7
|
Le Loarer F, Cleven AHG, Bouvier C, Castex MP, Romagosa C, Moreau A, Salas S, Bonhomme B, Gomez-Brouchet A, Laurent C, et al: A subset of epithelioid and spindle cell rhabdomyosarcomas is associated with TFCP2 fusions and common ALK upregulation. Mod Pathol. 33:404–419. 2020. View Article : Google Scholar : PubMed/NCBI
|
|
8
|
Dehner CA, Broski SM, Meis JM, Murugan P, Chrisinger JSA, Sosa C, Petersen M, Halling KC, Gupta S and Folpe AL: Fusion-driven spindle cell rhabdomyosarcomas of bone and soft tissue: A clinicopathologic and molecular genetic study of 25 cases. Mod Pathol. 36:1002712023. View Article : Google Scholar : PubMed/NCBI
|
|
9
|
Si C, Wang Y and Zhu J: A rare case report of intraosseous spindle and epithelioid rhabdomyosarcoma with TFCP2 rearrangement: A pathological diagnostic conundrum and literature review. Int J Surg Pathol. 33:125–130. 2025. View Article : Google Scholar : PubMed/NCBI
|
|
10
|
Panferova A, Sinichenkova KY, Abu Jabal M, Usman N, Sharlai A, Roshchin V, Konovalov D and Druy A: EWSR1-TFCP2 in an adolescent represents an extremely rare and aggressive form of intraosseous spindle cell rhabdomyosarcomas. Cold Spring Harb Mol Case Stud. 8:a0062092022. View Article : Google Scholar : PubMed/NCBI
|
|
11
|
Duan FL, Yang H, Gong X, Zuo Z, Qin S, Ji J, Zhou C, Dai J, Guo P and Liu Y: Clinicopathological features of rhabdomyosarcoma with novel FET::TFCP2 and TIMP3::ALK fusion: Report of two cases and literature review. Histopathology. 82:478–484. 2023. View Article : Google Scholar : PubMed/NCBI
|
|
12
|
Chen XY, Chen G, Zhu Q, Zhu WF, He C and Huang RF: Clinicopathological features of rhabdomyosarcoma with TFCP2 fusions. Zhonghua Bing Li Xue Za Zhi. 51:545–547. 2022.(In Chinese). PubMed/NCBI
|
|
13
|
Li HL, Mo CH, Xie L, Wu YX, Zeng M and Mao RJ: Clinicopathological study of epithelioid and spindle cell rhabdomysarcoma with EWSR1/FUS-TFCP2 fusion. Zhonghua Bing Li Xue Za Zhi. 53:58–63. 2024.(In Chinese). PubMed/NCBI
|
|
14
|
Carrillo-Ng H, Liang Y, Chang S, Afkhami M, Gernon T, Bell D and Arias-Stella JA: Complete mimicry: Rhabdomyosarcoma with FUS::TFCP2 fusion masquerading as carcinoma-diagnostic challenge and report of two cases. Genes Chromosomes Cancer. 62:430–436. 2023. View Article : Google Scholar : PubMed/NCBI
|
|
15
|
Demirkesen C, Danyeli AE, Yildiz P, Ertekin SS, Yilmaz B, Karahan SI and Bahrami A: Cutaneous rhabdomyosarcoma with FUS::TFCP2 fusion: A case report emphasizing early detection. J Cutan Pathol. 50:1059–1064. 2023. View Article : Google Scholar : PubMed/NCBI
|
|
16
|
Zhu G, Benayed R, Ho C, Mullaney K, Sukhadia P, Rios K, Berry R, Rubin BP, Nafa K, Wang L, et al: Diagnosis of known sarcoma fusions and novel fusion partners by targeted RNA sequencing with identification of a recurrent ACTB-FOSB fusion in pseudomyogenic hemangioendothelioma. Mod Pathol. 32:609–620. 2019. View Article : Google Scholar : PubMed/NCBI
|
|
17
|
Haug L, Doll J, Appenzeller S, Kunzmann V, Rosenwald A, Maurus K and Gerhard-Hartmann E: Epithelioid and spindle cell rhabdomyosarcoma with EWSR1::TFCP2 fusion mimicking metastatic lung cancer: A case report and literature review. Pathol Res Pract. 249:1547792023. View Article : Google Scholar : PubMed/NCBI
|
|
18
|
Chrisinger JSA, Wehrli B, Dickson BC, Fasih S, Hirbe AC, Shultz DB, Zadeh G, Gupta AA and Demicco EG: Epithelioid and spindle cell rhabdomyosarcoma with FUS-TFCP2 or EWSR1-TFCP2 fusion: Report of two cases. Virchows Arch. 477:725–732. 2020. View Article : Google Scholar : PubMed/NCBI
|
|
19
|
Koutlas IG, Olson DR and Rawwas J: FET(EWSR1)-TFCP2 Rhabdomyosarcoma: An additional example of this aggressive variant with predilection for the gnathic bones. Head Neck Pathol. 15:374–380. 2021. View Article : Google Scholar : PubMed/NCBI
|
|
20
|
Xu B, Suurmeijer AJH, Agaram NP, Zhang L and Antonescu CR: Head and neck rhabdomyosarcoma with TFCP2 fusions and ALK overexpression: A clinicopathological and molecular analysis of 11 cases. Histopathology. 79:347–357. 2021. View Article : Google Scholar : PubMed/NCBI
|
|
21
|
Silva Cunha JL, Cavalcante IL, da Silva Barros CC, Alves PM, Nonaka CFW, Albuquerque AFM, de Almeida OP, de Andrade BAB and Cavalcante RB: Intraosseous rhabdomyosarcoma of the maxilla with TFCP2 fusion: A rare aggressive subtype with predilection for the gnathic bones. Oral Oncol. 130:1058762022. View Article : Google Scholar : PubMed/NCBI
|
|
22
|
Valerio E, Furtado Costa JL, Perez Fraile NM, Credidio CH, Taveira Garcia MR, Neto CS and Costa FD: Intraosseous spindle Cell/Epithelioid rhabdomyosarcoma with TFCP2 rearrangement: A recent recognized subtype with partial response to alectinib. Int J Surg Pathol. 31:861–865. 2023. View Article : Google Scholar : PubMed/NCBI
|
|
23
|
Chen F, Wang J, Sun Y and Zhang J: Mandibular rhabdomyosarcoma with TFCP2 rearrangement and osteogenic differentiation: A case misdiagnosed as fibrous dysplasia or low-grade central osteosarcoma. Oral Surg Oral Med Oral Pathol Oral Radiol. 137:e143–e149. 2024. View Article : Google Scholar : PubMed/NCBI
|
|
24
|
Schöpf J, Uhrig S, Heilig CE, Lee KS, Walther T, Carazzato A, Dobberkau AM, Weichenhan D, Plass C, Hartmann M, et al: Multi-omic and functional analysis for classification and treatment of sarcomas with FUS-TFCP2 or EWSR1-TFCP2 fusions. Nat Commun. 15:512024. View Article : Google Scholar : PubMed/NCBI
|
|
25
|
Machado I, Wardelmann E, Zhao M, Song J, Wang Y, Braun SA, Catasus L, Ferre M, Leoveanu I, Westhoff J, et al: Primary cutaneous rhabdomyosarcoma with EWSR1/FUS::TFCP2 fusion: Four new cases with distinctive morphology, immunophenotypic, and genetic profile. Virchows Arch. 486:1187–1198. 2025. View Article : Google Scholar : PubMed/NCBI
|
|
26
|
Flaitz C and Hicks J: Primary Intraosseous Rhabdomyosarcoma: Rare Subtype Involving Mandible with Unique Translocation. Oral Surgery Oral Med Oral Pathol Oral Radiol. 133:1572022. View Article : Google Scholar
|
|
27
|
Zhong P, Wei S, Xiao H and Zeng Y: Rhabdomyosarcoma with FUS::TFCP2 fusion in the mandible: A rare aggressive subtype, but can be misdiagnosed as ossifying fibroma. Int J Surg Pathol. 32:758–766. 2024. View Article : Google Scholar : PubMed/NCBI
|
|
28
|
Gallagher KPD, Roza A, Tager E, Mariz B, Soares CD, Rocha AC, Abrahao AC, Romanach MJ, Carlos R, Hunter KD, et al: Rhabdomyosarcoma with TFCP2 rearrangement or typical Co-expression of AE1/AE3 and ALK: Report of three new cases in the head and neck region and literature review. Head Neck Pathol. 17:546–561. 2023. View Article : Google Scholar : PubMed/NCBI
|
|
29
|
Tagami Y, Sugita S, Kubo T, Iesato N, Emori M, Takada K, Tsujiwaki M, Segawa K, Sugawara T, Kikuchi T and Hasegawa T: Spindle cell rhabdomyosarcoma in a lumbar vertebra with FUS-TFCP2 fusion. Pathol Res Pract. 215:1523992019. View Article : Google Scholar : PubMed/NCBI
|
|
30
|
Dashti NK, Wehrs RN, Thomas BC, Nair A, Davila J, Buckner JC, Martinez AP, Sukov WR, Halling KC, Howe BM and Folpe AL: Spindle cell rhabdomyosarcoma of bone with FUS-TFCP2 fusion: Confirmation of a very recently described rhabdomyosarcoma subtype. Histopathology. 73:514–520. 2018. View Article : Google Scholar : PubMed/NCBI
|
|
31
|
Bradova M, Mosaieby E, Michal M, Vanecek T, Ing SK, Grossmann P, Koshyk O, Kinkor Z, Laciok S, Nemcova A, et al: Spindle cell rhabdomyosarcomas: With TFCP2 rearrangements, and novel EWSR1::ZBTB41 and PLOD2::RBM6 gene fusions. A study of five cases and review of the literature. Histopathology. 84:776–793. 2024. View Article : Google Scholar : PubMed/NCBI
|
|
32
|
Csizmok V, Grisdale CJ, Williamson LM, Lim HJ, Lee L, Renouf DJ, Jones SJM, Marra MA, Laskin J and Smrke A: Diagnostic and therapeutic implications of a FUS::TFCP2 fusion and ALK activation in a metastatic rhabdomyosarcoma. Genes Chromosomes Cancer. 63:e232592024. View Article : Google Scholar : PubMed/NCBI
|
|
33
|
Li Y, Li D, Wang J and Tang J: Epithelioid and spindle rhabdomyosarcoma with TFCP2 rearrangement in abdominal wall: A distinctive entity with poor prognosis. Diagn Pathol. 18:412023. View Article : Google Scholar : PubMed/NCBI
|
|
34
|
Fang Z, Duan C, Wang S, Fu L, Yang P, Yu T, Deel MD, Lau LMS, Ma X, Ni X and Su Y: Pediatric spindle cell/sclerosing rhabdomyosarcoma with FUS-TFCP2 fusion: A case report and literature review. Transl Pediatr. 13:178–191. 2024. View Article : Google Scholar : PubMed/NCBI
|
|
35
|
Plotzke JM, Rabah R, Robinson DR, Edmonds A, Bloom DA, Mody R and Heider A: Primary intraosseous spindle cell rhabdomyosarcoma: A case report in an unusual location. Pediatr Dev Pathol. 27:597–602. 2024. View Article : Google Scholar : PubMed/NCBI
|
|
36
|
Ma Y, Feng J, Ding D, Zhao J and Tian F: TFCP2-rearranged epithelioid and spindle cell rhabdomyosarcoma in the bladder: A rare case in an 8-year-old female child. Pediatr Blood Cancer. 70:e299352023. View Article : Google Scholar : PubMed/NCBI
|
|
37
|
Brunac AC, Laprie A, Castex MP, Laurent C, Le Loarer F, Karanian M, Le Guellec S, Guillemot D, Pierron G and Gomez-Brouchet A: The combination of radiotherapy and ALK inhibitors is effective in the treatment of intraosseous rhabdomyosarcoma with FUS-TFCP2 fusion transcript. Pediatr Blood Cancer. 67:e281852020. View Article : Google Scholar : PubMed/NCBI
|
|
38
|
Ginn MP, Denu RA, Ingram DR, Wani KM, Lazar AJ, Harrison DJ, Nakazawa MS, Conley AP, Patel S and Livingston JA: TFCP2 Fusion-Positive Rhabdomyosarcomas: A Report of 10 cases and a review of the literature. Cancers (Basel). 17:14412025. View Article : Google Scholar : PubMed/NCBI
|
|
39
|
Kotarba G, Krzywinska E, Grabowska AI, Taracha A and Wilanowski T: TFCP2/TFCP2L1/UBP1 transcription factors in cancer. Cancer Lett. 420:72–79. 2018. View Article : Google Scholar : PubMed/NCBI
|
|
40
|
Hsu WH, LaBella KA, Lin Y, Xu P, Lee R, Hsieh CE, Yang L, Zhou A, Blecher JM, Wu CJ, et al: Oncogenic KRAS drives lipofibrogenesis to promote angiogenesis and colon cancer progression. Cancer Discov. 13:2652–2673. 2023. View Article : Google Scholar : PubMed/NCBI
|
